Biotoc Regen Peel

Manufacturer
Dermafirm INC.
Effective date
2017-09-03
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:52:23

Label at a glance#

ProductBiotoc Regen Peel
Active ingredientADENOSINE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Adenosine

INACTIVE INGREDIENT SECTION

Water, Glycerin

OTC - PURPOSE SECTION

Anti-Wrinkle

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

Apply an appropriate amount of BIOTOC Regen Peel to pores and wrinkles especially around the lips and under the eyes.

Then massage roundly with your fingertips pressure for 2 or 3 minutes, and press firmly with your fingers.

Apply BIOTOC Serum and Cream thickly after using BIOTOC Regen Peel.

It is effective to use mask pack together.

For the best results, apply BIOTOC Regen Peel twice a week and BIOTOC Regen Ampoule, Serum, and Cream every morning and evening.

WARNINGS SECTION

1. Do not use in the following cases(Eczema and scalp wounds)
2.Side Effects
1)Due to the use of this druf if rash, irritation, itching and symptopms of hypersnesitivity occur dicontinue use and consult your phamacisr or doctor
3.General Precautions
1)If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately
2)This product is for exeternal use only. Do not use for internal use
4.Storage and handling precautions
1)If possible, avoid direct sunlight and store in cool and area of low humidity
2)In order to maintain the quality of the product and avoid misuse
3)Avoid placing the product near fire and store out in reach of children

DOSAGE & ADMINISTRATION SECTION

for external use only


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71638-0004-12021-01-29C16284748780-1ba0f9c33-0dd2-a910-e053-dadaa90a0b85Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71638-0004-1Biotoc Regen Peel13.5 g in 1 BOTTLE, WITH APPLICATORGEL13.51

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71638-0004BIOTOC REGEN PEEL (ADENOSINE) GEL [DERMAFIRM INC.]1Legacy NDC, 1 package rows20170904_58554a7e-90cd-f2da-e053-2991aa0af4dc.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71638-000471638-0004-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
GLYCERINPDC6A3C0OXIACT
ADENOSINEK72T3FS567ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
58554a7e-90ce-f2da-e053-2991aa0af4dc58554a7e-90cd-f2da-e053-2991aa0af4dc2017-09-03WarningsExact identifier
spl id: 58554a7e-90ce-f2da-e053-2991aa0af4dc
spl set id: 58554a7e-90cd-f2da-e053-2991aa0af4dc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.